Analysts Set RAPT Therapeutics, Inc. (NASDAQ:RAPT) PT at $5.29
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the […]
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the […]
